SPOTLIGHT: Levaquin approval expanded

by admin |

SPOTLIGHT ON... Levaquin approval expanded
Johnson & Johnson's short-course antibiotic Levaquin got the FDA's approval as a treatment for stubborn urinary-tract infections and kidney infection. Release

Suggested Articles

Scott Gottlieb FDA
Pharma

Ex-FDA chief Gottlieb considered for coronavirus 'czar': report

Trump has said the coronavirus outbreak doesn't pose a major threat to the U.S., but the White House is weighing naming a "czar," Politico…

by Eric Sagonowsky
Amarin Vascepa pill
Marketing

Amarin aims for Vascepa boom with doubled sales team nearly set

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

by Kyle Blankenship
Manufacturing

FDA spanks KVK Tech over impurities in ADHD drug

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

by Eric Palmer